tiprankstipranks
Circio Holding ASA Strengthens Capital for RNA Therapeutics
Company Announcements

Circio Holding ASA Strengthens Capital for RNA Therapeutics

Targovax ASA (GB:0RIS) has released an update.

Pick the best stocks and maximize your portfolio:

Circio Holding ASA is expanding its share capital through a conversion of convertible bonds into over 4 million new shares, following a request by Atlas Special Opportunities. This move comes alongside a financing commitment from Atlas to support Circio’s operations until mid-2025. As the company focuses on advancing its innovative RNA therapeutics, including a promising cancer vaccine, this financial restructuring aims to bolster its ambitious research and development agenda.

For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks European Auto-Generated NewsdeskCircio CTO Exercises Warrants Amidst RNA Tech Advances
TipRanks European Auto-Generated NewsdeskCircio Holding ASA Expands Share Capital Amid Therapeutics Focus
TipRanks European Auto-Generated NewsdeskCircio CEO Exercises Warrants Amid Biotech Advancements
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App